Elevance Health (ELV) EBIAT (2009 - 2026)

Elevance Health (ELV) has 18 years of EBIAT data on file, last reported at $1.8 billion in Q1 2026.

• Quarterly EBIAT fell 19.19% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 billion (down 11.18% YoY) and the FY2025 annual result came in at $5.7 billion, down 5.19% from the prior year.
• EBIAT climbed to $1.8 billion in Q1 2026 per ELV's latest filing, from $546.0 million in the prior quarter.
• Across five years, EBIAT topped out at $2.3 billion in Q2 2024 and bottomed at $409.0 million in Q4 2024.
• The 5-year median for EBIAT is $1.6 billion (2022), against an average of $1.5 billion.
• The widest annual swing landed in 2024, when EBIAT sank 50.54%; it then surged 33.5% in 2025.
• Tracing ELV's EBIAT over 5 years: stood at $859.0 million in 2022, then fell by 3.73% to $827.0 million in 2023, then slumped by 50.54% to $409.0 million in 2024, then soared by 33.5% to $546.0 million in 2025, then soared by 223.08% to $1.8 billion in 2026.
• Per Business Quant, the three latest ELV EBIAT figures stand at $1.8 billion (Q1 2026), $546.0 million (Q4 2025), and $1.2 billion (Q3 2025).

Peer Comparison